{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:18:26Z","timestamp":1794619106084,"version":"4.9.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001632","name":"Ulster University","doi-asserted-by":"publisher","award":["Vice Chancellors Studentship (Miller, N)"],"award-info":[{"award-number":["Vice Chancellors Studentship (Miller, N)"]}],"id":[{"id":"10.13039\/501100001632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Naloxone-based interventions as part of health systems can reverse an opioid overdose. Previous systematic reviews have identified the effectiveness of naloxone; however, the role of context and mechanisms for its use has not been explored. This realist systematic review aims to identify a theory of how naloxone works based on the contexts and mechanisms that contribute to the success of the intervention for improved outcomes.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Pre-registered at PROSPERO, this realist review followed RAMESES standards of reporting. Keywords included 'naloxone' and ' opioid overdose'. All study designs were included. Data extraction using 55 relevant outputs based on realist logic produced evidence of two middle-range theories: Naloxone Bystander Intervention Theory and Skills Transfer Theory.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Harm reduction and\/or low threshold contexts provide a non-judgemental approach which support in-group norms of helping and empower the social identity of the trained and untrained bystander. This context also creates the conditions necessary for skills transfer and diffusion of the intervention into social networks. Stigma and negative attitudes held by first responders and stakeholders involved in the implementation process, such as police or GPs, can prohibit the bystander response by inducing fear in responding. This interferes with skills transfer, naloxone use and carriage of naloxone kits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The findings provide theoretically informed guidance regarding the harm reduction\u00a0contexts that\u00a0are essential for the successful implementation of naloxone-based interventions. Peer-to-peer models of training are helpful as it reinforces social identity and successful skills transfer between bystanders. Health systems may want to assess the prevalence of, and take steps to\u00a0reduce opioid-related stigma with key stakeholders in contexts using a low threshold training approach to build an environment \u00a0to support positive naloxone outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>\n                           <jats:italic>Trial Registration<\/jats:italic>\n                        <\/jats:title>\n                <jats:p>PROSPERO 2019 CRD42019141003.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-022-00599-4","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T15:02:54Z","timestamp":1645801374000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["How do naloxone-based interventions work to reduce overdose deaths: a realist review"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5937-1629","authenticated-orcid":false,"given":"Nicole M.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8060-8053","authenticated-orcid":false,"given":"Bethany","family":"Waterhouse-Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3098-9326","authenticated-orcid":false,"given":"Claire","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5752-2297","authenticated-orcid":false,"given":"Gillian W.","family":"Shorter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,23]]},"reference":[{"key":"599_CR1","unstructured":"Ritchie H, Roser M. Drug use. 2020. https:\/\/ourworldindata.org\/drug-use.com. Accessed 4 May 2021."},{"key":"599_CR2","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1111\/j.1360-0443.2008.02314.x","volume":"103","author":"J Strang","year":"2008","unstructured":"Strang J, Manning V, Mayet S, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction. 2008;103:1648\u201357.","journal-title":"Addiction"},{"key":"599_CR3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.2105\/AJPH.2008.146647","volume":"99","author":"M Doe-Simkins","year":"2009","unstructured":"Doe-Simkins M, Walley AY, Epstein A, et al. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. AM J Public Health. 2009;99:788\u201391.","journal-title":"AM J Public Health"},{"key":"599_CR4","doi-asserted-by":"publisher","DOI":"10.3310\/cihr-nihr-01","volume-title":"Taking account of context in population health intervention research: guidance for producers, users and funders of research","author":"P Craig","year":"2018","unstructured":"Craig P, Di Ruggiero E, Frolich KL, et al. Taking account of context in population health intervention research: guidance for producers, users and funders of research. Southampton: National Institute for Health Research; 2018. https:\/\/doi.org\/10.3310\/cihr-nihr-01."},{"key":"599_CR5","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.drugpo.2015.09.011","volume":"26","author":"A McAuley","year":"2015","unstructured":"McAuley A, Aucott L, Matheson C. Exploring the life-saving potential of naloxone: a systematic review and descriptive meta-analysis of take home naloxone (THN) programmes for opioid users. Int J Drug Policy. 2015;26:1183\u20138.","journal-title":"Int J Drug Policy"},{"key":"599_CR6","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/add.13326","volume":"111","author":"R McDonald","year":"2016","unstructured":"McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 2016;111:1177\u201387.","journal-title":"Addiction"},{"key":"599_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/08897077.2015.1010032","volume":"36","author":"SR Mueller","year":"2015","unstructured":"Mueller SR, Walley AY, Calcaterra SL, et al. A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abuse. 2015;36:240\u201353.","journal-title":"Subst Abuse"},{"key":"599_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/ADM.0000000000000034","volume":"8","author":"AK Clark","year":"2014","unstructured":"Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014;8:153\u201363.","journal-title":"J Addict Med"},{"key":"599_CR9","doi-asserted-by":"crossref","unstructured":"Doleac JL, Mukherjee A. The moral hazard of lifesaving innovations: naloxone access, opioid abuse, and crime. 2018. https:\/\/ssrn.com\/abstract=3170278. Accessed 5 Mar 2021.","DOI":"10.2139\/ssrn.3170278"},{"key":"599_CR10","unstructured":"Ndrianasy E. The opioid crisis: naloxone access laws and moral hazard. PhD [dissertation]. Tennessee: Middle Tennessee State University; 2019. https:\/\/jewlscholar.mtsu.edu\/bitstream\/handle\/mtsu\/6085\/Ndrianasy_mtsu_0170E_11203.pdf?sequence=1&isAllowed=y."},{"key":"599_CR11","unstructured":"Wong G, Westhorp G, Pawson R, et al. Realist synthesis: rameses training materials. 2013. https:\/\/www.ramesesproject.org\/media\/Realist_reviews_training_materials.pdf. Accessed 5 Sept 2019."},{"key":"599_CR12","doi-asserted-by":"publisher","DOI":"10.4135\/9781849209120","volume-title":"Evidence based policy: a realist perspective","author":"R Pawson","year":"2006","unstructured":"Pawson R. Evidence based policy: a realist perspective. London: Sage; 2006."},{"issue":"1_suppl","key":"599_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1258\/1355819054308530","volume":"10","author":"R Pawson","year":"2005","unstructured":"Pawson R, Greenhalgh T, Harvey G, et al. Realist review-a new method of systematic review designed for complex policy interventions. J Heath Serv Res Pol. 2005;10(1_suppl):21\u201334.","journal-title":"J Heath Serv Res Pol"},{"key":"599_CR14","doi-asserted-by":"publisher","first-page":"E153","DOI":"10.9778\/cmajo.20140008","volume":"2","author":"O Banjo","year":"2014","unstructured":"Banjo O, Tzemis D, Al-Qutub D, et al. A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program. CMAJ Open. 2014;2:E153\u201361. https:\/\/doi.org\/10.9778\/cmajo.20140008.","journal-title":"CMAJ Open"},{"key":"599_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3109\/09687637.2012.658104","volume":"19","author":"T Bennett","year":"2012","unstructured":"Bennett T, Holloway K. The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: an evaluation of the THN Project in Wales. Drugs Edu Prev Pol. 2012;19:320\u20138. https:\/\/doi.org\/10.3109\/09687637.2012.658104.","journal-title":"Drugs Edu Prev Pol"},{"key":"599_CR16","unstructured":"Clarke A, Eustace A. Evaluation of the HSE Naloxone Demonstration Project. 2016. https:\/\/www.drugsandalcohol.ie\/26037\/1\/Naloxonedemoproject.pdf. Accessed 5 Sept 2019."},{"key":"599_CR17","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1136\/bmj.322.7291.895","volume":"322","author":"K Dettmer","year":"2001","unstructured":"Dettmer K, Saunders B, Strang J. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ. 2001;322:895\u20136.","journal-title":"BMJ"},{"key":"599_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-297","author":"M Doe-Simkins","year":"2014","unstructured":"Doe-Simkins M, Quinn E, Xuan Z, et al. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health. 2014. https:\/\/doi.org\/10.1186\/1471-2458-14-297.","journal-title":"BMC Public Health"},{"key":"599_CR19","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5811\/westjem.2015.2.24909","volume":"16","author":"K Dwyer","year":"2015","unstructured":"Dwyer K, Walley AY, Langlois BK, et al. Opioid education and nasal naloxone rescue kits in the emergency department. WestJem. 2015;16:381.","journal-title":"WestJem"},{"key":"599_CR20","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.17269\/cjph.104.3788","volume":"104","author":"PN Leece","year":"2013","unstructured":"Leece PN, Hopkins S, Marshall C, et al. Development and implementation of an opioid overdose prevention and response program in Toronto, Ontario. Can J Public Health. 2013;104:e200\u20134.","journal-title":"Can J Public Health"},{"key":"599_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3109\/09687630802530712","volume":"17","author":"A McAuley","year":"2010","unstructured":"McAuley A, Lindsay G, Woods M, et al. Responsible management and use of a personal take-home naloxone supply: a pilot project. Drugs Educ Prev Pol. 2010;17:388\u201399.","journal-title":"Drugs Educ Prev Pol"},{"key":"599_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/jurban\/jti053","volume":"82","author":"KH Seal","year":"2005","unstructured":"Seal KH, Thawley R, Gee L, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health. 2005;82:303\u201311. https:\/\/doi.org\/10.1093\/jurban\/jti053.","journal-title":"J Urban Health"},{"key":"599_CR23","unstructured":"Shorter G, Bingham T. Service review: take home Naloxone programme in NI consultation with service users and service providers. 2016. https:\/\/www.drugsandalcohol.ie\/25353\/1\/PHANI_Naloxone-service-evaluation-final-report.pdf. Accessed 1 June 2019."},{"key":"599_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.drugpo.2009.01.003","volume":"21","author":"KD Wagner","year":"2010","unstructured":"Wagner KD, Valente TW, Casanova M, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy. 2010;21:186\u201393. https:\/\/doi.org\/10.1016\/j.drugpo.2009.01.003.","journal-title":"Int J Drug Policy"},{"key":"599_CR25","doi-asserted-by":"publisher","first-page":"f-174","DOI":"10.1136\/bmj.f174","volume":"346","author":"AY Walley","year":"2013","unstructured":"Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f-174. https:\/\/doi.org\/10.1136\/bmj.f174.","journal-title":"BMJ"},{"key":"599_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1037\/h0026570","volume":"10","author":"B Latane","year":"1968","unstructured":"Latane B, Darley J. Group inhibition of bystander intervention in emergencies. J Pers Soc Psychol. 1968;10:215\u201321. https:\/\/doi.org\/10.1037\/h0026570.","journal-title":"J Pers Soc Psychol"},{"key":"599_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/9781444307948.ch11","volume-title":"The psychology of prosocial behavior group processes, intergroup relations, and helping","author":"M Levine","year":"2009","unstructured":"Levine M, Cassidy C. Groups, identities, and bystander behavior. In: St\u00fcrmer S, Snyder M, editors. The psychology of prosocial behavior group processes, intergroup relations, and helping. Oxford: Blackwell Publishing; 2009. p. 209\u201322. https:\/\/doi.org\/10.1002\/9781444307948.ch11."},{"key":"599_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9781118736982","volume-title":"The Wiley Blackwell handbook of the psychology of training development and performance improvement","author":"K Kraiger","year":"2014","unstructured":"Kraiger K, Passmore J, Dos Santos N, et al. The psychology of training, development, and performance improvement. In: Kraiger K, Passmore J, Dos Santos N, Malvezz S, editors., et al., The Wiley Blackwell handbook of the psychology of training development and performance improvement. Hoboken: Wiley; 2014. p. 1\u20139."},{"key":"599_CR29","first-page":"S123","volume":"11","author":"R Orfaly","year":"2005","unstructured":"Orfaly R, Frances J, Campbell P, et al. Train-the-trainer as an educational model in public health preparedness. JPHMP. 2005;11:S123\u20137.","journal-title":"JPHMP"},{"key":"599_CR30","volume-title":"Training the trainer","author":"CC Veri","year":"1971","unstructured":"Veri CC, Vonder Haar TA. Training the trainer. Missouri: Extension Division University of Missouri-St Louis; 1971."},{"key":"599_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/JAN.0000000000000230","volume":"29","author":"L Chimbar","year":"2018","unstructured":"Chimbar L, Moleta Y. Naloxone effectiveness: a systematic review. J Addict Nurs. 2018;29:167\u201371.","journal-title":"J Addict Nurs"},{"key":"599_CR32","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Preventing fatal overdoses: a\u00a0systematic review of the effectiveness of take-home naloxone. 2015. https:\/\/www.emcdda.europa.eu\/publications\/emcdda-papers\/naloxone-effectiveness_en. Accessed 5 Sept 2019."},{"key":"599_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.drugpo.2017.05.015","volume":"46","author":"M Horton","year":"2017","unstructured":"Horton M, McDonald R, Green TC, et al. A mapping review of take-home naloxone for people released from correctional settings. Int J Drug Policy. 2017;46:7\u201316.","journal-title":"Int J Drug Policy"},{"key":"599_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.drugpo.2016.02.006","volume":"32","author":"S Nielsen","year":"2016","unstructured":"Nielsen S, Van Hout MC. What is known about community pharmacy supply of naloxone? A scoping review. Int J Drug Policy. 2016;32:24\u201333.","journal-title":"Int J Drug Policy"},{"key":"599_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/15563650.2016.1253846","volume":"55","author":"MW Willman","year":"2017","unstructured":"Willman MW, Liss DB, Schwarz ES, et al. Do heroin overdose patients require observation after receiving naloxone? Clin Toxicol. 2017;55:81\u20137.","journal-title":"Clin Toxicol"},{"key":"599_CR36","unstructured":"Ruane L. The overdose drug Naloxone can save lives so let's remove the barriers to accessing it. The Journal IE [Internet]. 2019 April 14. Cited 5 Sept 20. https:\/\/www.thejournal.ie\/readme\/lynn-ruane-naloxone-can-save-the-life-of-people-who-overdose-lets-remove-all-barriers-to-access-4589304-Apr2019\/."},{"key":"599_CR37","unstructured":"Public health agency. Take Home Naloxone Report on supply and use to reverse an overdose. 2012-2016. 2016. https:\/\/www.publichealth.hscni.net\/sites\/default\/files\/Take%20Home%20Naloxone%20Report%202012-16_0.pdf. Accessed 5 Sept 2019"},{"key":"599_CR38","unstructured":"Center for Disease Control. National Vital Statistics Rapid Release Provisional Drug Overdose Death Counts. 2021. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm. Accessed 2 Jan 2021."},{"key":"599_CR39","unstructured":"National Institute for Health development. Opioids overdose deaths prevention programme in Estonia. https:\/\/intra.tai.ee\/\/images\/prints\/documents\/154651154294_NaloksoonEestis_eng.pdf. Accessed 5 June 2019."},{"key":"599_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1177\/1049732318800289","volume":"29","author":"JM Bowles","year":"2019","unstructured":"Bowles JM, Lankenau SE. \u201cI gotta go with modern technology, so i\u2019m gonna give \u2019em the Narcan\u201d: the diffusion of innovations and an opioid overdose prevention program. Qual Health Res. 2019;29:345\u201356. https:\/\/doi.org\/10.1177\/1049732318800289.","journal-title":"Qual Health Res"},{"key":"599_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.drugpo.2008.02.004","volume":"20","author":"SG Sherman","year":"2009","unstructured":"Sherman SG, Gann DS, Tobin KE, et al. \u201cThe life they save may be mine\u201d: diffusion of overdose prevention information from a city sponsored programme. Int J Drug Policy. 2009;20:137\u201342. https:\/\/doi.org\/10.1016\/j.drugpo.2008.02.004.","journal-title":"Int J Drug Policy"},{"key":"599_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-015-1949-1","volume":"15","author":"J Jagosh","year":"2015","unstructured":"Jagosh J, Bush PL, Salsberg J, et al. A realist evaluation of community-based participatory research: partnership synergy, trust building and related ripple effects. BMC Public Health. 2015;15:1\u201311. https:\/\/doi.org\/10.1186\/s12889-015-1949-1.","journal-title":"BMC Public Health"},{"key":"599_CR43","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.05.2010.2986","author":"S George","year":"2010","unstructured":"George S, Boulay S, Begley D. I saved a life\u201d: a heroin addict\u2019s reflections on managing an overdose using \u201ctake home naloxone. BMJ Case Rep. 2010. https:\/\/doi.org\/10.1136\/bcr.05.2010.2986.","journal-title":"BMJ Case Rep"},{"key":"599_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1300\/J069v25n03_11","volume":"25","author":"S Maxwell","year":"2006","unstructured":"Maxwell S, Bigg D, Stanczykiewicz K, et al. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25:89\u201396.","journal-title":"J Addict Dis"},{"key":"#cr-split#-599_CR45.1","unstructured":"Olsen A, McDonald D, Lenton S, et al. Independent evaluation of the 'Implementing Expanded Naloxone Availability in the ACT (I-ENAACT)'Program, 2011-2014 Final report. Canberra: ACT Health. 2015. Updated 2015 August"},{"key":"#cr-split#-599_CR45.2","unstructured":"cited 5 Sept 2019. https:\/\/www.health.act.gov.au\/sites\/default\/files\/2018-09\/Naloxone%20Evaluation%20Report_Aug_2015.pdf."},{"key":"599_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7517-3-19","volume":"3","author":"N Worthington","year":"2006","unstructured":"Worthington N, Piper TM, Galea S, et al. Opiate users\u2019 knowledge about overdose prevention and naloxone in New York City: a focus group study. Harm Reduct J. 2006;3:1\u20137. https:\/\/doi.org\/10.1186\/1477-7517-3-19.","journal-title":"Harm Reduct J"},{"key":"599_CR47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10900-012-9591-7","volume":"39","author":"SE Lankenau","year":"2013","unstructured":"Lankenau SE, Wagner KD, Silva K, et al. Injection drug users trained by overdose prevention programs: responses to witnessed overdose. J Community Health. 2013;39:133\u201341. https:\/\/doi.org\/10.1007\/s10900-012-9591-7.","journal-title":"J Community Health"},{"key":"599_CR48","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1111\/add.12961","volume":"110","author":"C Rowe","year":"2015","unstructured":"Rowe C, Santos GM, Vittinghoff E, et al. Predictors of participant engagement and naloxone utilization in a community-based naloxone distribution program. Addiction. 2015;110:1301\u201310. https:\/\/doi.org\/10.1111\/add.12961.","journal-title":"Addiction"},{"key":"599_CR49","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.drugalcdep.2017.06.029","volume":"179","author":"A Siegler","year":"2017","unstructured":"Siegler A, Huxley-Reicher Z, Maldjian L, et al. Naloxone use among overdose prevention trainees in New York City: a longitudinal cohort study. Drug Alcohol Depend. 2017;179:124\u201330. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.06.029.","journal-title":"Drug Alcohol Depend"},{"key":"599_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7517-5-2","volume":"5","author":"SG Sherman","year":"2008","unstructured":"Sherman SG, Gann DS, Scott G, et al. A qualitative study of overdose responses among Chicago IDUs. Harm Reduct J. 2008;5:1\u20135. https:\/\/doi.org\/10.1186\/1477-7517-5-2.","journal-title":"Harm Reduct J"},{"key":"599_CR51","unstructured":"Nelson M, Lenton S, Dietze P, et al. Evaluation of the WA peer naloxone project\u2013final report.\u00a0Report for Western Australia: National Drug Research Institute, Perth. 2016. https:\/\/www.researchgate.net\/profile\/Anna_Olsen\/publication\/307605397_Evaluation_of_the_WA_Peer_Naloxone_Project_Final_Report\/links\/58ce0370aca27233551623db\/Evaluation-of-the-WA-Peer-Naloxone-Project-Final-Report.pdf. Accessed 5 Sept 2019."},{"key":"599_CR52","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.drugpo.2013.07.003","volume":"25","author":"KD Wagner","year":"2014","unstructured":"Wagner KD, Davidson PJ, Iverson E, et al. \u201cI felt like a superhero\u201d: the experience of responding to drug overdose among individuals trained in overdose prevention. Int J Drug Policy. 2014;25:157\u201365. https:\/\/doi.org\/10.1016\/j.drugpo.2013.07.003.","journal-title":"Int J Drug Policy"},{"key":"599_CR53","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1007\/s11524-011-9600-7","volume":"88","author":"AS Bennett","year":"2011","unstructured":"Bennett AS, Bell A, Tomedi L, et al. Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. J Urban Health. 2011;88:1020\u201330. https:\/\/doi.org\/10.1007\/s11524-011-9600-7.","journal-title":"J Urban Health"},{"key":"599_CR54","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/08897077.2015.1135850","volume":"37","author":"L Maldjian","year":"2016","unstructured":"Maldjian L, Siegler A, Kunins HV. Evaluation of overdose prevention trainings in New York City: knowledge and self- efficacy among participants 12 months after training. Subst Abuse. 2016;37:459\u201365. https:\/\/doi.org\/10.1080\/08897077.2015.1135850.","journal-title":"Subst Abuse"},{"key":"599_CR55","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.drugpo.2008.03.002","volume":"20","author":"KE Tobin","year":"2009","unstructured":"Tobin KE, Sherman SG, Beilenson P, et al. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009;20:131\u20136. https:\/\/doi.org\/10.1016\/j.drugpo.2008.03.002.","journal-title":"Int J Drug Policy"},{"key":"599_CR56","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1300\/J069v26n04_08","volume":"26","author":"CT Baca","year":"2007","unstructured":"Baca CT, Grant KJ. What heroin users tell us about overdose. J Addict Dis. 2007;26:63\u20138. https:\/\/doi.org\/10.1300\/J069v26n04_08.","journal-title":"J Addict Dis"},{"issue":"suppl_2","key":"599_CR57","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1111\/j.1526-4637.2011.01128.x","volume":"12","author":"S Albert","year":"2011","unstructured":"Albert S, Brason FW, Sanford CK, et al. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med. 2011;12(suppl_2):S77\u201385.","journal-title":"Pain Med"},{"key":"599_CR58","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/injuryprev-2017-042396","volume":"24","author":"AA Alexandridis","year":"2018","unstructured":"Alexandridis AA, McCort A, Ringwalt CL, et al. A state-wide evaluation of seven strategies to reduce opioid overdose in North Carolina. Inj Prev. 2018;24:48\u201354.","journal-title":"Inj Prev"},{"key":"599_CR59","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jsat.2005.05.010","volume":"30","author":"T Lagu","year":"2006","unstructured":"Lagu T, Anderson BJ, Stein M. Overdoses among friends: drug users are willing to administer naloxone to others. J Subst Abuse Treat. 2006;30:129\u201333.","journal-title":"J Subst Abuse Treat"},{"key":"599_CR60","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2105\/AJPH.2016.303141","volume":"106","author":"DA Lewis","year":"2016","unstructured":"Lewis DA, Park JN, Vail L, et al. Evaluation of the overdose education and naloxone distribution program of the Baltimore student harm reduction coalition. Am J Public Health. 2016;106:1243\u20136.","journal-title":"Am J Public Health"},{"key":"599_CR61","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.ajem.2015.05.022","volume":"33","author":"J Rando","year":"2015","unstructured":"Rando J, Broering D, Olson JE, et al. Intranasal naloxone administration by police first responders is associated with decreased opioid overdose deaths. Am J Emerg Med. 2015;33:1201\u20134.","journal-title":"Am J Emerg Med"},{"key":"599_CR62","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugalcdep.2016.05.008","volume":"165","author":"KD Wagner","year":"2016","unstructured":"Wagner KD, Bovet LJ, Haynes B, et al. Training law enforcement to respond to opioid overdose with naloxone: impact on knowledge, attitudes, and interactions with community members. Drug Alcohol Depend. 2016;165:22\u20138.","journal-title":"Drug Alcohol Depend"},{"key":"599_CR63","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.2105\/AJPH.2015.302638","volume":"105","author":"CS Davis","year":"2015","unstructured":"Davis CS, Carr D, Southwell JK, et al. Engaging law enforcement in overdose reversal initiatives: authorization and liability for naloxone administration. Am J Public Health. 2015;105:1530\u20137.","journal-title":"Am J Public Health"},{"key":"599_CR64","unstructured":"European network of people who use drugs. Peer to Peer distribution of naloxone (P2PN). 2019. https:\/\/www.euronpud.net\/naloxone. Accessed 5 May 2020"},{"key":"599_CR65","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.drugpo.2016.11.015","volume":"41","author":"C Marshall","year":"2017","unstructured":"Marshall C, Perreault M, Archambault L, et al. Experiences of peer-trainers in a take-home naloxone program: results from a qualitative study. Int J Drug Policy. 2017;41:19\u201328.","journal-title":"Int J Drug Policy"},{"key":"599_CR66","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.addbeh.2018.09.027","volume":"89","author":"KM Waye","year":"2019","unstructured":"Waye KM, Goyer J, Dettor D, et al. Implementing peer recovery services for overdose prevention in Rhode Island: an examination of two outreach-based approaches. Addict Behav. 2019;89:85\u201391.","journal-title":"Addict Behav"},{"key":"599_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1017\/S1481803500010010","volume":"10","author":"C Vaillancourt","year":"2008","unstructured":"Vaillancourt C, Stiell IG, Wells GA. Understanding and improving low bystander CPR rates: a systematic review of the literature. CJEM. 2008;10:51\u201365.","journal-title":"CJEM"},{"key":"599_CR68","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addbeh.2018.03.014","volume":"86","author":"C McClellan","year":"2018","unstructured":"McClellan C, Lambdin BH, Ali MM, et al. Opioid-overdose laws association with opioid use and overdose mortality. Addict Behav. 2018;86:90\u20135.","journal-title":"Addict Behav"},{"key":"599_CR69","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1177\/0033354920915439","volume":"135","author":"KE Schneider","year":"2020","unstructured":"Schneider KE, Park JN, Allen ST, et al. Knowledge of good samaritan laws and beliefs about arrests among persons who inject drugs a year after policy change in Baltimore, Maryland. Public Health Rep. 2020;135:393\u2013400.","journal-title":"Public Health Rep"},{"key":"599_CR70","unstructured":"Annual Statutes-Good Samaritan Drug Overdose Act 2017 (Canada) S.C.2017. c.4. https:\/\/laws.justice.gc.ca\/eng\/AnnualStatutes\/2017_4\/page-1.html."},{"key":"599_CR71","doi-asserted-by":"publisher","first-page":"e0130050","DOI":"10.1371\/journal.pone.0130050","volume":"10","author":"MA Bachhuber","year":"2015","unstructured":"Bachhuber MA, McGinty EE, Kennedy-Hendricks A, et al. Messaging to increase public support for naloxone distribution policies in the United States: results from a randomized survey experiment. PLoS ONE. 2015;10:e0130050.","journal-title":"PLoS ONE"},{"key":"599_CR72","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1360-0443.2011.03601.x","volume":"107","author":"JD Livingston","year":"2012","unstructured":"Livingston JD, Milne T, Fang ML, et al. The effectiveness of interventions for reducing stigma related to substance use disorders: a systematic review. Addiction. 2012;107:39\u201350.","journal-title":"Addiction"},{"key":"599_CR73","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","volume":"20","author":"T Rhodes","year":"2009","unstructured":"Rhodes T. Risk environments and drug harms: a social science for harm reduction approach. Int J Drug Policy. 2009;20:193\u2013201.","journal-title":"Int J Drug Policy"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00599-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-022-00599-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00599-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T14:04:22Z","timestamp":1646316262000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-022-00599-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,23]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1186\/s12954-022-00599-4","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,23]]},"assertion":[{"value":"12 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}